KEYMETLA

Swiss trademark · 605313 · Word mark · Deleted

Register entry

Registration number
605313
Application number
55074/2010
Status
Deleted
Type
Word mark
Filed
May 20, 2010
Registered
Sep 15, 2010
Published
Sep 15, 2010
Deleted
Dec 15, 2020
Reason
Not renewed
Priority
11.12.2009 US
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmaceutical preparations for human use

As filed

Pharmazeutische Präparate zur Anwendung beim Menschen.

Translated automatically. Only the text as filed is legally binding.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 15, 2020

    Deleted, not renewed

    Published in Swissreg on 15.12.2020

  2. Oct 6, 2020

    Agent’s address changed

    Representative
    Schneider Feldmann AG, Patent- und Markenanwälte, Beethovenstrasse 49, Postfach, 8027 Zürich → Keller Schneider Patent- und Markenanwälte AG (Zürich), Beethovenstrasse 49, Postfach, 8027 Zürich

    Published in Swissreg on 06.10.2020

  3. Apr 19, 2017

    Agent’s address changed

    Representative
    Schneider Feldmann AG, Patent- und Markenanwälte, Beethovenstrasse 49,, Postfach 2792, 8022 Zürich → Schneider Feldmann AG, Patent- und Markenanwälte, Beethovenstrasse 49, Postfach, 8027 Zürich

    Published in Swissreg on 19.04.2017

  4. May 6, 2014

    Transferred

    Owner
    Bristol-Myers Squibb Company, 345 Park Avenue, New York, NY 10154, USA → AstraZeneca AB, Vastra Malarehamnen 9, 15185 Södertälje, Sweden
    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich → Schneider Feldmann AG, Patent- und Markenanwälte, Beethovenstrasse 49,, Postfach 2792, 8022 Zürich

    Published in Swissreg on 06.05.2014

  5. Sep 15, 2010

    Registered

    Published in Swissreg on 15.09.2010

Parties

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.